The health care industry's campaign of fear, uncertainty and doubt

By Wendell Potter

Commentary: health insurers use a host of tactics to erode support for Obamacare.

Reader-approved analysis from Wendell Potter

By Sarah Whitmire

Revisit some of the best analysis from former health insurance exec-turned-whistleblower, Wendell Potter.

Excerpts from this story referencing "Medicare":

"… on is the requirement that all Americans not covered by a public plan like Medicare or Medicaid must buy coverage from a private insurance company. The second …"

OPINION: drug firms say no to rebates, despite billions in new revenue from Part D

By Wendell Potter

Part D brought drug companies billions, but they say the sky is falling

Excerpts from this story referencing "Medicare Part D":

"… also eligible for Medicaid because of their low incomes.  Before the Medicare Part D drug program was created in 2006, the pharmaceutical industry paid rebates …"

"… s." And this: “The President has again proposed to upend the successful Medicare Part D prescription drug program by imposing government price controls on it.” …"

OPINION: Big Pharma's stranglehold on Washington

By Wendell Potter

Pharmaceutical firms are getting their money's worth on Capitol Hill.

Excerpts from this story referencing "Medicare":

"… affect health insurance premiums, but it also impacts the solvency of our Medicare system, which was expanded in 2006 to include a prescription drug benefit. …"

"… ded in 2006 to include a prescription drug benefit. That was good news for Medicare beneficiaries, of course, but even better news for the pharmaceutical indu …"

"… nd the White House at the time) went along with Big Pharma’s demand that Medicare not be allowed to negotiate pricing with drug makers to make medicines mor …"

"… n with drug makers to get better deals on prices. But, incredibly, not the Medicare program. The Congressional Budget Office estimates that the government co …"

Drug lobby gave $750,000 to pro-Hatch nonprofit in Utah's U.S. Senate race

By Michael Beckel

IRS records show drug lobby helped Utah senator, others.

Excerpts from this story referencing "National Institute":

"… $87,000 while Sheehy raised roughly $67,000, according to the nonpartisan National Institute on Money in State Politics. Group’s origins questioned In 2010, Hatch …"

Analysis — Are seniors paying attention to Paul Ryan's plan for Medicare?

By Wendell Potter

ANALYSIS: Republicans sold seniors a bill of goods on health care reform and Medicare

Excerpts from this story referencing "Medicare":

"… because of the spin they were sold about how “Obamacare” would affect Medicare played a big role in returning the House of Representatives to Republican …"

"… hey're paying attention to what Rep. Paul Ryan, R-Wis., wants to do to the Medicare program, are having some serious buyer’s remorse. If Democrats are wise, …"

"… se. If Democrats are wise, they’re already drafting a strategy to remind Medicare beneficiaries, including card-carrying Tea Party members, just how fooled …"

"… ny senior citizens were snookered about how reform legislation would alter Medicare. Shortly after I testified before Congress about how the insurance industr …"

Tobacco company penalties may signal U.S. crackdown on industry practices overseas

By Traver Riggins and Ricardo Sandoval Palos

A flurry of federal enforcement action targeting payoffs by subsidiaries of two U.S. tobacco companies may signal a broader regulatory assau

The top ten PACs that will miss Chris Dodd

By Aaron Mehta and Josh Israel

When Connecticut Democrat Chris Dodd first ran for the Senate in 1980, his campaign cost only about $1.4 million. But three decades later, r

How do health care lobby dollars match influence in Congress?

By Adam Clark Estes

Who's really paying for and benefiting from reform?

Commentary: Changing Washington: The hard part

By Bill Buzenberg

The difficulty overcoming the entrenched political tradition of earmarks is just one of many hard realities that will test the Obama Adminis

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

The economy may be sliding, but that hasn’t stemmed the high-rolling habits of Washington’s largest lobby. In 2007, as the Center recently r

A record year for the pharmaceutical lobby in '07

By M. Asif Ismail

Washington's largest lobby racks up another banner year on Capitol Hill

FDA staff travels on drug industry dollars

By Alexander Cohen

Groups tied to FDA-regulated industry paying for agency officials' trips

FDA: A shell of its former self

By M. Asif Ismail

The Food and Drug Administration lacks the power to regulate pharmaceuticals and keep you safe

Surrogates for their agenda

By Alexander Cohen

How the drug industry uses non-profits to push its interests

Drug industry influence timeline

What the pharmaceutical industry has gotten on its political investment

Excerpts from this story referencing "Medicare Part D":

"… addition to the cost of the vaccine itself) is included in the coverage of Medicare Part D drugs.In June, House Democrats announce plans to introduce legislation pre …"

Exporting prices

By M. Asif Ismail

Drug makers' trade group makes the industry's priorities U.S. trade policy

PhRMA's envoys

By M. Asif Ismail

Former ambassador lobbies Canadians on drug imports to U.S.

The state money race

By Derek Willis

Democrats outraised GOP in the states, but have little to show for it

Excerpts from this story referencing "Republican Party":

"… dollars needed to be used for the expenditure. For example, the Tennessee Republican Party aired a television spot attacking U.S. Senate candidate Bob Clement's reco …"

"… n Senatorial Committee sent nearly $5.6 million in soft money to Florida's Republican Party—despite the lack of a Senate race in Florida in 2002. In turn, Florida's …"

"… (See National GOP Exchanges Soft Money for Hard in Florida.)Florida's Republican Party also was able to send money to state party committees in California, Georg …"

"… candidate can bring into a small state can transform a race, said Vermont Republican Party Chairman Jim Barnett."In a tiny state like this, it doesn't take much to c …"

Silent Partners: Special Report

By Derek Willis and Aron Pilhofer

How political non-profits work the system

Lobbying, old-time politics block legislation on human cloning

By M. Asif Ismail

Bush administration articulates no position

Excerpts from this story referencing "University of Washington":

"… do it."Philip Bereano, a professor of technology and public policy at the University of Washington, agreed. "The industry, of course, wants the least legislation. They didn' …"

"… "There is a very strong pro-research lobby in the United States," said the University of Washington's Bereano. Influential academics from elite universities are the leaders o …"

"… n to embryonic manipulation [which leads to cloning]," said Bereano of the University of Washington.Hayes added that recent advances in stem cell research make it all the mor …"

Commentary: How Bush handles McCain will set tone for his presidency

By Charles Lewis

WASHINGTON, January 23, 2001 — Now that George W. Bush has been duly sworn in as the 43rd president of the United States, he immediately fac

Montana an unlikely target for out-of-state campaign cash

WASHINGTON, October 25, 2000 — Montana might not seem like the logical setting for a full-scale brawl over a U.S. Senate seat, but with the

Stealth PACs revealed

By The Center for Public Integrity

February 9, 2000 — The 2000 election cycle promised to be a high-stakes and free-spending election by anyone's measure. The balance of power

Excerpts from this story referencing "Cato Institute":

"… Wall Street stockbroker Richard Gilder and Stephen Moore, president of the Cato Institute, a libertarian think tank. Of the founding members, only Gilder anted up m …"

Chemical industry among big spenders on lobbying this quarter

By Dave Levinthal

New numbers indicate it's still good to be a lobbyist in America.

Excerpts from this story referencing "American Chemistry Council":

"… ore on lobbying thanks to its “successful 2013 earnings results.” The American Chemistry Council’s lobbying spending jumped from $1.9 million during the first quarter of …"

OPINION: favors for special interests

By Wendell Potter

Insurers, drug companies get what they want from Congress; the public, not so much

Excerpts from this story referencing "Medicare":

"… to kill health care reform if serious consideration was given to allowing Medicare officials to negotiate for lower drug prices. We hear constantly from law …"

"… rug prices. We hear constantly from lawmakers about how unsustainable the Medicare “entitlement” program is,  yet when they had a chance to make a d …"

"… gram is,  yet when they had a chance to make a difference in how much Medicare has to shell out to drug makers, they looked the other way. Taxpayers coul …"

"… y looked the other way. Taxpayers could save billions of dollars a year if Medicare didn’t have to pay so much for drugs, but drug companies have much more …"

Drug lobby donation went to pro-Democratic nonprofit

By Michael Beckel

Half-million-dollar donation from PhRMA went to little-known group that backed Harry Reid.

Heart testing bill signed by Perry required unnecessary tests, critics charge

By Rochelle Sharpe

Medical experts say measure signed by Perry requires unnecessary testing

Excerpts from this story referencing "Medicare":

"… Donnella says he is working to convince large employers as well as federal Medicare officials to cover the tests. …"

Pages